Imprivata recorded $76 million in sales during the year ended March 31, 2014, according to NASDAQ. The IPO is expected to give the company a diluted market value of about $387 million.
More Articles on IPOs:
21st Century Oncology Launches IPO
10 Things To Know About Castlight Health’s IPO
IMS Health’s $1.3B IPO Shows Investors Recognize Value of Big Data
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
